Language selection

Government of Canada / Gouvernement du Canada

Search

Biologics in Canada.: H82-50/1-2020E-PDF ; H82-50/2-2020E-PDF

"This analysis examines the market dynamics of biologics in Canada and compares Canadian and international trends in sales, pricing, and biosimilar uptake. Part 2 uses recent Canadian and international trends to expose the current and future cost savings that could be realized through increasing the uptake and/or lowering the prices of biosimilars in Canada"--Introduction, page 5.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.885926&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board, issuing body.
TitleBiologics in Canada.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • "May 2020."
  • Cover title.
  • Issued also in HTML format.
  • "Chartbook National Prescription Drug Utilization Information System (NPDUIS)"--Cover.
  • Issued also in French under title: Les médicaments biologiques au Canada.
  • Includes bibliographical references (page 31).
  • Part 1: Market trends, 2018 -- Part 2: Biosimilar savings, 2018.
Publishing information
  • Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2020.
  • ©2020
Description1 online resource (2 volumes) : graphs
ISBN9780660345949 9780660345956
Catalogue number
  • H82-50/1-2020E-PDF
  • H82-50/2-2020E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: